Nuclear Medicine: Page 68

PET tracer may aid understanding of brain aging

By AuntMinnie.com staff writers

A new PET imaging radiotracer may help advance the understanding of neurodegenerative disease and the aging brain, according to research published in the October issue of the Journal of Nuclear Medicine.

October 4, 2018

FDG-PET/CT fails for peripheral T-cell lymphoma outcomes

By Wayne Forrest

Don't expect much help from FDG-PET/CT results in predicting progression-free or overall survival among patients with peripheral T-cell lymphoma, according to a study published in the October issue of Clinical Lymphoma, Myeloma and Leukemia.

October 4, 2018

MITA hails proposed Medicare radiopharmaceutical bill

By AuntMinnie.com staff writers

The Medical Imaging and Technology Alliance (MITA) is praising the introduction of bipartisan legislation in the U.S. House of Representatives that would recognize diagnostic radiopharmaceuticals as drugs in the Medicare Hospital Outpatient Prospective Payment System.

October 3, 2018

WMIS honors Gillies with Gold Medal award

By AuntMinnie.com staff writers

The World Molecular Imaging Society (WMIS) has given Robert Gillies, PhD, its highest honor -- the Gold Medal.

October 2, 2018

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

October 2, 2018

PET/CT predicts success of rad therapy for spinal mets

By Wayne Forrest

FDG-PET/CT scans can predict the success of radiation therapy in patients with spinal metastases, especially in regard to progression-free survival, according to a study published online September 28 in PLOS One.

October 2, 2018

PET/MRI motion correction gives readers more confidence

By Wayne Forrest

A motion correction algorithm applied to PET/MRI scans resulted in more accurate scans with fewer false positives, and readers were more confident in their interpretations, according to study results published in the September issue of the Journal of Nuclear Medicine.

October 1, 2018

FluoroPharma restructures CardioPET license with MGH

By AuntMinnie.com staff writers

Radiopharmaceutical developer FluoroPharma Medical has restructured its license agreement with Massachusetts General Hospital (MGH) in Boston for the radiopharmaceutical CardioPET.

September 26, 2018

PET/CT key to NIH's tuberculosis research plan

By AuntMinnie.com staff writers

The U.S. National Institute of Allergy and Infectious Diseases has published a new plan for tuberculosis research, and imaging -- particularly PET/CT -- is a key part of the strategy. The document was released on September 26 to coincide with the United Nations General Assembly meeting in New York City on ending tuberculosis.

September 25, 2018

FDG-PET/CT helps stage men with breast cancer, too

By Wayne Forrest

Assessing breast cancer in men is an uncommon clinical use for FDG-PET/CT, but the hybrid modality achieves results comparable to those in women in regard to accurate staging of the disease, according to a study published online September 21 in the Journal of Nuclear Medicine.

September 25, 2018

Ga-68 PSMA-11 PET/MRI advances prostate cancer detection

By Wayne Forrest

PET/MRI scans with a gallium-68 (Ga-68)-labeled radiopharmaceutical that homes in on prostate-specific membrane antigen (PSMA)-11 could become a mainstay in prostate cancer detection, given its ability to significantly outperform multiparametric MRI alone, according to a study published online September 18 in Radiology.

September 24, 2018

Flortaucipir-PET targets tau for Alzheimer's diagnoses

By Wayne Forrest

By binding to the tau protein associated with Alzheimer's, PET imaging with the tracer flortaucipir can distinguish between the disease and other neurodegenerative conditions with similar symptoms, according to an international study published in the September 18 issue of the Journal of the American Medical Association.

September 20, 2018

Previous Page

Page 68 of 438

Next Page